patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: emma, up because of this "The Wall Street Journal's Market Watch"

Pluristem Therapeutics Inc.’s /quotes/comstock/15*!psti/quotes/nls/psti (PSTI 2.96, +0.38, +14.75%) shares gained 14% after Needham & Co. initiated coverage of the developer of cell-therapy products with a buy recommendation.

http://www.marketwatch.com/story/mondays-biggest-gaining-and-declining-stocks-2011-04-04

Share
New Message
Please login to post a reply